{
  "abstract": "Protzenko et al address a question that hospital pharmacists encounter regularly: in older and frail patients with atrial fibrillation, how should concerns about bleeding influence dosing of non-vitamin K oral anticoagulants (NOACs)? Their local analysis is therefore clinically relevant. The point that merits a more cautious interpretation, however, is not the observation that underdosing occurred, but the strength of the inferences drawn from a small retrospective cohort and the extent to which the predictive model can be regarded as clinically actionable.1",
  "authors": [
    {
      "affiliations": [
        "Dr D Y Patil Vidyapeeth (Deemed to be University), Pune, MH, India"
      ],
      "name": "Umakant Mokalikar"
    },
    {
      "affiliations": [
        "Faculty of Pharmaceutical Sciences, Graphic Era Hill University, Dehradun, India",
        "Graphic Era Deemed to be University, Dehradun, UK, India"
      ],
      "name": "Reenoo Jauhari²˒"
    },
    {
      "affiliations": [
        "Department of Pharmaceutics, Noida Institute of Engineering & Technology (Pharmacy Institute), Noida, India"
      ],
      "name": "Anjna Rani"
    },
    {
      "affiliations": [
        "Chitkara University, Rajpura, India"
      ],
      "name": "Rajesh Singh"
    }
  ],
  "title": "Correspondence on ‘Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach’ by Protzenko et al",
  "uid": "67ce51ff-b27a-5095-861f-dbf7bf7cb9d6"
}